Key result
In resistance arteries from patients with cardiovascular disease, ET-1 does not selectively modify smooth muscle relaxing responses to NO or H2O2.
Why the study?
Does ET-1 modify the relaxing responses to NO or H2O2 in human pericardial resistance arteries?
Does ET-1 modify the relaxing responses to NO or H2O2 in human pericardial resistance arteries?
ET-1 does not selectively modify smooth muscle relaxing responses to NO or H2O2 in human pericardial resistance arteries, and H2O2 acts as an endothelium-dependent vasodilator.
No selective ET-1 effect on NO/H2O2 relaxation in diseased human resistance arteries; hypothesis-generating for endothelial mechanisms.
In human pericardial resistance arteries, effects of the endothelium‐dependent vasodilator bradykinin are mediated by NO during contraction induced by K + or the TxA 2 analogue U46619 and by H 2 O 2 during contraction by endothelin‐1 ( ET ‐1), respectively. We tested the hypotheses that ET ‐1 reduces relaxing effects of NO and increases those of H 2 O 2 in resistance artery smooth muscle of patients with cardiovascular disease. Arterial segments, dissected from the parietal pericardium of 39 cardiothoracic surgery patients, were studied by myography during amplitude‐matched contractions induced by K + , the TXA 2 analogue U46619 or ET ‐1. Effects of the NO donor Na‐nitroprusside ( SNP ) and of exogenous H 2 O 2 were recorded in the absence and presence of inhibitors of cyclooxygenases, NO synthases and small and intermediate conductance calcium‐activated K + channels. During contractions induced by either of the three stimuli, the potency of SNP did not differ and was not modified by the inhibitors. In vessels contracted with ET ‐1, the potency of H 2 O 2 was on average and in terms of interindividual variability considerably larger than in K + ‐contracted vessels. Both differences were not statistically significant in the presence of inhibitors of mechanisms of endothelium‐dependent vasodilatation. In resistance arteries from patients with cardiovascular disease, ET ‐1 does not selectively modify smooth muscle relaxing responses to NO or H 2 O 2 . Furthermore, the candidate endothelium‐derived relaxing factor H 2 O 2 also acts as an endothelium‐dependent vasodilator.
No takes yet. Share an insight, caveat, or question.
Leurgans et al. (2017) studied Cardiovascular disease (n=39). Endothelin-1 (ET-1) vs. K+ or U46619 was evaluated on Potency of SNP (NO donor) and exogenous H2O2. In resistance arteries from patients with cardiovascular disease, ET-1 does not selectively modify smooth muscle relaxing responses to NO or H2O2.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: